Cortisol has one of the most distinct and fascinating circadian rhythms in human physiology. This is regulated by the central clock located in the suprachiasmatic nucleus of the hypothalamus. It has been suggested that cortisol acts as a secondary messenger between central and peripheral clocks, hence its importance in the synchronization of body circadian rhythms. Conventional immediate-release hydrocortisone, either at twice- or thrice-daily doses, is not capable of replicating physiological cortisol circadian rhythm and patients with adrenal insufficiency or congenital adrenal hyperplasia still suffer from a poor quality of life and increased mortality. Novel treatments for replacement therapy are therefore essential. Proof-of-concept studies using hydrocortisone infusions suggest that the circadian delivery of hydrocortisone may improve biochemical control and life quality in patients lacking cortisol with an impaired cortisol rhythm. Recently oral formulations of modified-release hydrocortisone are being developed and it has been shown that it is possible to replicate cortisol circadian rhythm and also achieve better control of morning androgen levels. These new drug therapies are promising and potentially offer a more effective treatment with less adverse effects. Definite improvements clearly need to be established in future clinical trials.
al-Shoumer, K.A., Beshyah, S.A., Niththyananthan, R. and Johnston, D.G. ( 1995) Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults. Clin Endocrinol (Oxf) 42: 85-90.
2.
Arlt, W. and Allolio, B. ( 2003) Adrenal insufficiency. Lancet361: 1881-1893.
3.
Arlt, W., Rosenthal, C., Hahner, S. and Allolio, B. ( 2006) Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clin Endocrinol (Oxf) 64: 384-389.
4.
Balsalobre, A., Brown, S.A., Marcacci, L., Tronche, F., Kellendonk, C., Reichardt, H.M. et al. (2000) Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science289: 2344-2347.
5.
Balsalobre, A., Damiola, F. and Schibler, U. ( 1998) A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell93: 929-937.
6.
Bergthorsdottir, R., Leonsson-Zachrisson, M., Oden, A. and Johannsson, G. ( 2006) Premature mortality in patients with Addison’s disease: a population-based study. J Clin Endocrinol Metab91: 4849-4853.
7.
Bleicken, B., Hahner, S., Loeffler, M., Ventz, M., Decker, O., Allolio, B. et al. (2010) Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 72: 297-304.
8.
Buckley, T.M. and Schatzberg, A.F. ( 2005) On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab90: 3106-3114.
9.
Buijs, R.M. and Kalsbeek, A. ( 2001) Hypothalamic integration of central and peripheral clocks . Nat Rev Neurosci2: 521-526.
10.
Debono, M., Ghobadi, C., Rostami-Hodjegan, A., Huatan, H., Campbell, M.J., Newell-Price, J. et al. (2009) Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab94: 1548-1554.
11.
Derendorf, H., Mollmann, H., Barth, J., Mollmann, C., Tunn, S. and Krieg, M. ( 1991) Pharmacokinetics and oral bioavailability of hydrocortisone . J Clin Pharmacol31: 473-476.
Esteban, N.V. and Yergey, A.L. ( 1990) Cortisol production rates measured by liquid chromatography/ mass spectrometry. Steroids55: 152-158.
14.
Fahrenkrug, J., Hannibal, J. and Georg, B. ( 2008) Diurnal rhythmicity of the canonical clock genes Per1, Per2 and Bmal1 in the rat adrenal gland is unaltered after hypophysectomy . J Neuroendocrinol20: 323-329.
15.
Filipsson, H., Monson, J.P., Koltowska-Haggstrom, M., Mattsson, A. and Johannsson, G. ( 2006) The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab91: 3954-3961.
16.
Garcia-Borreguero, D., Wehr, T.A., Larrosa, O., Granizo, J.J., Hardwick, D., Chrousos, G.P. et al. (2000) Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency. J Clin Endocrinol Metab85: 4201-4206.
17.
Groves, R.W., Toms, G.C., Houghton, B.J. and Monson, J.P. ( 1988) Corticosteroid replacement therapy: twice or thrice daily ? J R Soc Med81: 514-516.
18.
Hahner, S., Loeffler, M., Fassnacht, M., Weismann, D., Koschker, A.C., Quinkler, M. et al. (2007) Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis . J Clin Endocrinol Metab92: 3912-3922.
19.
Hastings, M.H. ( 1997) Central clocking. Trends Neurosci20: 459-464.
20.
Hastings, M.H. and Herzog, E.D. ( 2004) Clock genes, oscillators, and cellular networks in the suprachiasmatic nuclei. J Biol Rhythms19: 400-413.
21.
Heshmati, H.M., Riggs, B.L., Burritt, M.F., McAlister, C.A., Wollan, P.C. and Khosla, S. ( 1998) Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women. J Clin Endocrinol Metab83: 751-756.
22.
Howlett, T.A. ( 1997) An assessment of optimal hydrocortisone replacement therapy . Clin Endocrinol (Oxf) 46: 263-268.
23.
Ishida, A., Mutoh, T., Ueyama, T., Bando, H., Masubuchi, S., Nakahara, D. et al. (2005) Light activates the adrenal gland: timing of gene expression and glucocorticoid release. Cell Metab2: 297-307.
24.
Jasper, M.S. and Engeland, W.C. ( 1997) Splanchnicotomy increases adrenal sensitivity to ACTH in nonstressed rats. Am J Physiol273: E363-E368.
25.
Johannsson, G., Bergthorsdottir, R., Nilsson, A.G., Lennernas, H., Hedner, T. and Skrtic, S.(2009) Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Eur J Endocrinol161: 119-130.
26.
Kerrigan, J.R., Veldhuis, J.D., Leyo, S.A., Iranmanesh, A. and Rogol, A.D. ( 1993) Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab76: 1505-1510.
27.
Krieger, D.T., Allen, W., Rizzo, F. and Krieger, H.P. ( 1971) Characterization of the normal temporal pattern of plasma corticosteroid levels. J Clin Endocrinol Metab32: 266-284.
28.
Linder, B.L., Esteban, N.V., Yergey, A.L., Winterer, J.C., Loriaux, D.L. and Cassorla, F. ( 1990) Cortisol production rate in childhood and adolescence . J Pediatr117: 892-896.
29.
Lovas, K. and Husebye, E.S. ( 2007) Continuous subcutaneous hydrocortisone infusion in Addison’s disease. Eur J Endocrinol157: 109-112.
30.
Lovas, K. and Husebye, E.S. ( 2008) Replacement therapy for Addison’s disease: recent developments. Expert Opin Investig Drugs17: 497-509.
31.
Lovas, K., Husebye, E.S., Holsten, F. and Bjorvatn, B. ( 2003) Sleep disturbances in patients with Addison’s disease . Eur J Endocrinol148: 449-456.
32.
Lovas, K., Loge, J.H. and Husebye, E.S. ( 2002) Subjective health status in Norwegian patients with Addison’s disease. Clin Endocrinol (Oxf) 56: 581-588.
33.
Mah, P.M., Jenkins, R.C., Rostami-Hodjegan, A., Newell-Price, J., Doane, A., Ibbotson, V. et al. (2004) Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency . Clin Endocrinol (Oxf) 61: 367-375.
34.
Meijer, J.H. and Schwartz, W.J. ( 2003) In search of the pathways for light-induced pacemaker resetting in the suprachiasmatic nucleus. J Biol Rhythms18: 235-249.
35.
Merza, Z., Rostami-Hodjegan, A., Memmott, A., Doane, A., Ibbotson, V., Newell-Price, J. et al. (2006) Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 65: 45-50.
36.
Mills, J.L., Schonberger, L.B., Wysowski, D.K., Brown, P., Durako, S.J., Cox, C. et al. (2004) Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr144: 430-436.
37.
Moeller, H. ( 1985) Chronopharmacology of hydrocortisone and 9 alpha-fluorhydrocortisone in the treatment for congenital adrenal hyperplasia. Eur J Pediatr144: 370-373.
38.
Moore-Ede, M.C., Czeisler, C.A. and Richardson, G.S. ( 1983) Circadian timekeeping in health and disease. Part 1. Basic properties of circadian pacemakers. N Engl J Med309: 469-476.
39.
Moore, R.Y. and Lenn, N.J. ( 1972) A retinohypothalamic projection in the rat. J Comp Neurol146: 1-14.
40.
Oelkers, W. ( 1996) Adrenal insufficiency. N Engl J Med335: 1206-1212.
41.
Oster, H., Damerow, S., Hut, R.A. and Eichele, G. ( 2006a) Transcriptional profiling in the adrenal gland reveals circadian regulation of hormone biosynthesis genes and nucleosome assembly genes. J Biol Rhythms21: 350-361.
42.
Oster, H., Damerow, S., Kiessling, S., Jakubcakova, V., Abraham, D., Tian, J. et al. (2006b) The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock. Cell Metab4: 163-173.
43.
Peacey, S.R., Guo, C.Y., Robinson, A.M., Price, A., Giles, M.A., Eastell, R. et al. (1997) Glucocorticoid replacement therapy: are patients over treated and does it matter?Clin Endocrinol ( Oxf) 46: 255-261.
44.
Plat, L., Byrne, M.M., Sturis, J., Polonsky, K.S., Mockel, J., Fery, F. et al. (1996) Effects of morning cortisol elevation on insulin secretion and glucose regulation in humans. Am J Physiol270: E36-E42.
45.
Reddy, P., Zehring, W.A., Wheeler, D.A., Pirrotta, V., Hadfield, C., Hall, J.C. et al. (1984) Molecular analysis of the period locus in Drosophila melanogaster and identification of a transcript involved in biological rhythms . Cell38: 701-710.
46.
Reppert, S.M. and Weaver, D.R. ( 2001) Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol63: 647-676.
47.
Rollag, M.D., Berson, D.M. and Provencio, I. ( 2003) Melanopsin, ganglion-cell photoreceptors, and mammalian photoentrainment. J Biol Rhythms18: 227-234.
48.
Rosenfeld, P., van Eekelen, J.A., Levine, S. and de Kloet, E.R.(1993) Ontogeny of corticosteroid receptors in the brain. Cell Mol Neurobiol13: 295-319.
49.
Rubin, R.P. ( 2007) A brief history of great discoveries in pharmacology: in celebration of the centennial anniversary of the founding of the American Society of Pharmacology and Experimental Therapeutics. Pharmacol Rev59: 289-359.
50.
Savage, O. ( 1951) Cortisone and ACTH. Postgrad Med J27: 70-77.
51.
Selmaoui, B. and Touitou, Y. ( 2003) Reproducibility of the circadian rhythms of serum cortisol and melatonin in healthy subjects: a study of three different 24-h cycles over six weeks. Life Sci73: 3339-3349.
52.
Silver, R., LeSauter, J., Tresco, P.A. and Lehman, M.N. ( 1996) A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature382: 810-813.
53.
Spath-Schwalbe, E., Scholler, T., Kern, W., Fehm, H.L. and Born, J. ( 1992) Nocturnal adrenocorticotropin and cortisol secretion depends on sleep duration and decreases in association with spontaneous awakening in the morning. J Clin Endocrinol Metab75: 1431-1435.
54.
Verma, S., Vanryzin, C., Sinaii, N., Kim, M.S., Nieman, L.K., Ravindran, S. et al. (2010) A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia . Clin Endocrinol (Oxf) 72: 441-447.
55.
Vitaterna, M.H., King, D.P., Chang, A.M., Kornhauser, J.M., Lowrey, P.L., McDonald, J.D. et al. (1994) Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science264: 719-725.
56.
Weitzman, E.D., Fukushima, D., Nogeire, C., Roffwarg, H., Gallagher, T.F. and Hellman, L. ( 1971) Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab33: 14-22.
57.
Wichers, M., Springer, W., Bidlingmaier, F. and Klingmuller, D. ( 1999) The influence of hydrocortisone substitution on the quality of life and parameters of bone metabolism in patients with secondary hypocortisolism . Clin Endocrinol (Oxf) 50: 759-765.
58.
Zelissen, P.M., Croughs, R.J., van Rijk, P.P. and Raymakers, J.A.(1994) Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Ann Intern Med120: 207-210.
59.
Zylka, M.J., Shearman, L.P., Weaver, D.R. and Reppert, S.M. ( 1998) Three period homologs in mammals: differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain. Neuron20: 1103-1110.
